|
|
|
Press Release: Ninth International Pharma Compliance Congress Features Global Chief Compliance Officer Roundtable
|
- A Hybrid Conference and Internet Event
- Sponsored by ethics, the International Society of Healthcare Compliance Professionals
- Co-sponsored by the Pharmaceutical Compliance Forum
- May 11 - 13, 2015
- Onsite at the Crowne Plaza Brussels - Le Palace in Brussels, Belgium
- In Your Own Office or Home live via the Internet with 24/7 Access for Six Months
- www.InternationalPharmaCongress.com
PRESS RELEASE
Phone: 800-503-8171
Email: registration@hcconferences.com
Website: www.InternationalPharmaCongress.com |
EARLY BIRD REGISTRATION
- SAVE UP TO €200 -
|
Register by Friday, April 10, 2015 for Early Bird Discount and save up to €200.
Click here to register.
|
|
|
FEATURING GLOBAL CHIEF COMPLIANCE OFFICER ROUNDTABLE
|
Martin Fürle
Vice President, General Counsel and Chief Compliance Officer, Daiichi Sankyo Europe GmbH, Munich, Germany |
Thomas K. Hauser, MA, HSG
Global Chief Compliance Officer, Siemens Healthcare; Board Member, ETHICS, Erlangen, Germany |
Mwana Lugogo
Corporate Officer, Global Compliance Officer, Takeda Pharmaceuticals International GmbH, Zurich, Switzerland
|
Jeff Rosenbaum
Vice President, Chief Compliance Officer, Vertex Pharmaceuticals; Former Executive Director, Global Head of Ethics and Compliance, Novartis Oncology, Boston, MA, USA |
Kris Curry
Principal, Fraud Investigation and Dispute Services, EY; Former Vice President, Health Care Compliance, Pharmaceuticals Group, Johnson & Johnson, Philadelphia, PA, USA (Moderator)
|
|
|
|
BRUSSELS, BELGIUM -- MARCH 30, 2015: The Ninth International Pharmaceutical Compliance Congress, www.InternationalPharmaCongress.com, will take place on May 11 - 13, 2015 at the Crowne Plaza Brussels - Le Palace in Brussels, Belgium. Registrants may attend the event in person or online (live webcast and archived for 6 months).
|
|
KEYNOTE SPEAKERS
|
Robert Barrington, PhD
Executive Director, Transparency International-UK, London, UK |
Richard Bergström
Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA), Former Director General, LIF Sweden, Brussels, Belgium
|
Marc de Garidel
Chairman and Chief Executive Officer, Ipsen, Vice President, European Federation of the, Pharmaceutical Industries and Associations (EFPIA), Knight, National Order of the Legion of Honor (France), Paris, France |
Brendan Shaw, PhD
Assistant Director General, International Federation of Pharmaceutical, Manufacturers and Associations (IFPMA), Former Chief Executive, Medicines Australia, Geneva, Switzerland
|
|
|
|
FEATURING AN EFPIA STAKEHOLDER WORKSHOP
|
The European Federation of Pharmaceutical Industries and Associations (EFPIA) is offering an independent EFPIA STAKEHOLDER WORKSHOP on Monday, May 11, 2014.
|
|
FEATURING PLENARY SESSIONS
|
|
|
- Keynote Address: Innovation, Ethics and Compliance
- Keynote Address: The C-Suite Perspective
- European Commission Keynote Address
- Transparency International Keynote Address
- Global Chief Compliance Officer Roundtable
- Understanding the New Life Sciences Marketplace
- The New Marketplace: The Purchasers Perspective
- Roundtable on Compliance Issues Raised by the Changing Marketplace
- IFPMA International Codes Update
- Global Transparency Roundtable
- Anticorruption 2.0: Thinking Strategically/Managing Risks
- Crafting the Compliance Program of the Future
- The Evolution of the Role and Responsibility of Compliance Professionals
|
INTERNATIONAL PHARMA
CONGRESS IS
|
|
|
|
|
AND MINI SUMMITS
|
- Mini Summit I: Basic Compliance Concepts and Skills I
- Mini Summit II: How to Engage Medical Societies with Conference Organizers
- Mini Summit III: Competition/Antitrust Law Update
- Mini Summit IV: Global Transparency, Disclosure and Aggregate Spend Update
- Mini Summit V: Annual Central and Eastern European (CEE) Compliance Update
- Mini Summit VI: Basic Compliance Concepts and Skills II
- Mini Summit VII: Global Compliance Auditing and Monitoring Best Practices
- Mini Summit VIII: What's Next in Global Compliance?
- Mini Summit IX: Clinical Trials Compliance
- Mini Summit X: Data Analytics Supporting Compliance Monitoring, Risk Prevention and Mitigation
- Mini Summit XI: Advanced Strategies in Compliance Training
- Mini Summit XII: Annual Middle East/Africa European (MEA) Compliance Update
- Mini Summit XIII: Medical Device Compliance Issues Update
- Mini Summit XIV: Advanced Issues in Anti-corruption Compliance
- Mini Summit XV: Best Practices in Third Party Supplier Management
|
|
|
|
A CHIEF COMPLIANCE OFFICERS ROUNDTABLE
|
Martin Fürle
Vice President, General Counsel & Chief Compliance Officer, DAIICHI SANKYO EUROPE GmbH, Munich, Germany |
Thomas K. Hauser, LLM
Chief Compliance Officer, Siemens Healthcare, Board Member, ETHICS, Nürnberg, Germany |
Mwana Lugogo
Corporate Officer, Global Compliance Officer, Takeda Pharmaceuticals International GmbH, Zurich, Switzerland
|
Jeff Rosenbaum
Vice President, Chief Compliance Officer, Vertex Pharmaceuticals, Former Executive Director, Global Head of Ethics & Compliance Novartis Oncology, Boston, MA, USA |
Kris Curry
Principal, Fraud Investigation and Dispute Services, Ernst & Young LLP, Former Vice President, Health Care Compliance, Pharmaceuticals Group, Johnson & Johnson, Philadelphia, PA, USA (Moderator)
|
|
|
|
THE NEW MARKETPLACE: THE PURCHASER PERSPECTIVE
|
Günter Danner, MA, PhD
Associate Director, European Representation, German Social Insurance, Brussels, Belgium |
Klaus Hilleke, PhD
Chief Executive Officer and Head, Global Life Science Division, Simon-Kucher & Partners, Bonn, Germany |
Frank Wartenberg, PhD
President, Central Europe, IMS Health, Frankfurt/Main, Germany
|
Andrew White
Head of Medicine Management - NHS, Greater Manchester Commissioning Support Unit, Manchester, UK |
Olivier Wong, MD
Specialist in Family Medicine; Former Voting Member, French Transparency Committee, Paris, France
|
|
|
|
ANTICORRUPTION 2.0 PANEL
|
Ted Acosta, Esq.
Principal, Fraud Investigation & Dispute Services, EY, Former Senior Counsel, Office of Inspector General, United States Department of Health and Human Services, New York, NY, USA and Paris, France |
Peter Dieners, Esq.
Partner and Head, Global Healthcare and Life Sciences Group, Clifford Chance, Co-chair, Legal Affairs Focus Group (LA FG), EUCOMED, Co-chair, Compliance Network (CN), EUCOMED, Düsseldorf, Germany |
Nathaniel Edmonds, Esq.
Partner, Paul Hastings; Former Assistant Chief, Foreign Corrupt Practices Act (FCPA), Fraud Section in the Criminal Division, United States Department of Justice, Washington, DC, USA
|
Patrick Moulette
Head, Anti-Corruption Division, Directorate for Financial and Enterprise Affairs, Organisation for Economic Co-operation and Development (OECD), Paris, France |
Joseph B. Tompkins, Jr.
Partner, Sidley Austin LLP, Former Deputy Chief of the Fraud Section, Criminal Division, United States Department of Justice, Washington, DC, USA
|
|
|
|
CENTRAL AND EASTERN EUROPE (CEE) COMPLIANCE UPDATE
|
Paul J. Melling, Esq.
Founding Partner, Baker & McKenzie - CIS, Limited, Moscow, Russia |
Madina Plieva, PhD
Legal Director, Association of International, Pharmaceutical Manufacturers (AIPM), Former Head of Legal Department, Kutafin Moscow State Law Academy, Moscow, Russia
|
Dumitru Uta, MD, MBA, CCEP
Ethics and Compliance Director, South-East Europe, Eli Lilly and Company, Bucharest, Romania |
Mariusz Witalis
Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Warsaw, Poland (Moderator)
|
|
|
|
MIDDLE EAST/AFRICA (MEA) COMPLIANCE ROUNDTABLE
|
Flavia Bollinger
Head Integrity and Compliance MENA (Middle East, North Africa), Novartis Pharma Services AG, Dubai, UAE |
Zeynep Didem Degirmencioglu
Head of Compliance, Intercontinental Region, Merck KGaA, Istanbul, Turkey |
Dr. Yacoub Haddad
Government Affairs Director MEAP Region, Abbvie, Chair, Pharmaceutical Research and Manufacturers Association, Gulf (PhRMAG), Dubai, UAE
|
Laura Nassar
Head of Compliance, Middle East Sub-Regions I & II, Hoffmann-La Roche Ltd. (Dubai Branch), Dubai, UAE |
Khaled Mansour
Area Managing Director, Middle East, West Asia and Africa, Janssen, Chair, MEA Regional Ethics Group (LERB), Cairo, Egypt (Moderator)
|
|
|
|
FEATURED FACULTY
|
Annalisa Ponchia Baccara, CMP, CMM
Executive Officer, European Society for Organ Transplantation (ESOT), Padova, Italy |
Brian K. Beeler, MBA, JD
Senior Vice President, Legal and Chief Compliance Officer, Horizon Pharma, Dublin, Ireland |
Andy Bender
President and Founder, Polaris, New York, NY, USA
|
Katrina Cahill
Global Transparency Lead, Biogen Idec, Weston, MA |
Fiona Carlin, LLB
Managing Partner, European & Competition Law Practice, Baker & McKenzie, Brussels, Belgium |
Holger Diener, PhD
Managing Director, Association of Voluntary, Self-Regulation for the Pharmaceutical Industry, Berlin, Germany
|
Suzanne Durdevic, LLM
Senior Director, General Counsel, EMEA, Boston Scientific International; Chair, Legal Affairs Focus Group, EUCOMED; Member, Strategic Committee, ETHICS, Paris, France |
Kip Ebel, MBA
Principal, Ernst & Young, New York, NY |
Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK
|
Eva Gardyan-Eisenlohr
Esquire (Germany)/DIAP (ENA, Paris), General Counsel and Compliance Officer, Bayer Pharma AG, Member, Strategic Committee, ETHICS, Berlin, Germany |
George Fife
Executive Director, Compliance & Ethics, Bristol-Myers Squibb, Former, Compliance & Internal Audit Leader, EMEA, GE Healthcare, Paris, France |
Jacques Fontas
Executive Counsel, Compliance Leader, GE, Healthcare Europe; Member, Strategic Committee, ETHICS, Paris, France
|
Dario Ghoddousi
Senior Vice President Global Transparency and MDM Solutions, Cegedim, Paris, France |
Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY
|
Cécile Gousset
Associate Vice President Compliance Risk Assessment, Education and Monitoring, Global Compliance, Sanofi, Member, Strategic Committee, ETHICS, Paris, France
|
Ulf H. Grundmann, JD
Partner, Life Science Practice Group, King and Spalding, Frankfurt, Germany |
Catherine Higgs, MA Cantab
Senior Legal Counsel, AstraZeneca, Alderley, UK |
Erinn Hutchinson
Partner, Advisory Services, PricewaterhouseCoopers, Philadelphia, PA
|
Carl Judge
Director, Fraud Investigation & Dispute Services, EY, London, UK |
Isaure Kergall-Gayet, DEA-Law
Compliance & Business Integrity Director, France, Global Compliance & Business Integrity Department, Sanofi, Former VP, Chief Ethics & Compliance Officer, Ipsen, Paris, France |
Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC
|
Daniel A. Kracov, Esq.
Partner and Head, FDA and Healthcare Practice, Arnold & Porter, Washington, DC, USA |
Aline Lautenberg
General Counsel - Director Legal & Compliance, Eucomed, EDMA and MedTech Europe, Brussels, Belgium |
Angelique Lee-Rowley, Esq.
Vice President, Associate General Counsel and Compliance Officer Spectrum Pharmaceuticals, Inc., Former Director, Compliance, Siemens Healthcare, Irvine, CA, USA
|
Alice Lex, PhD
Health Care Compliance Officer, Janssen Research and Development in EMEA, Johnson & Johnson, Neuss, Germany |
Michael K. Loucks, Esq.
Partner, Skadden Arps LLP, Former Acting United States Attorney, District of Massachusetts, Washington, DC, USA |
Maurits J.F. Lugard, MA, JD, LLM
Partner, Sidley Austin LLP, Former Member of the European Commission's Legal Service, Brussels, Belgium
|
Jean McKiernan
Director, Advisory Pharmaceutical and Life Sciences, PwC LLP, Chicago, IL, USA |
Stephen Nguyen-Duc
Office of Ethics & Compliance Regional Director . International Operations, Western Europe & Canada, Abbvie, Former Director, Ethics & Compliance Officer, Member of the Executive Committee, Eli Lilly, Member, Strategic Committee Member, ETHICS, Paris, France |
John Patrick Oroho, Esq.
Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ, USA
|
David O'Shaughnessy
Vice President, Compliance, Emerging Markets, Quintiles, Board Member, ETHICS, Former Vice President Compliance, International Pharmaceuticals, GSK, Former Vice President, Global Compliance Strategy, AstraZeneca, Reading, UK |
Pascale Paimbault
Compliance Officer, France -Benelux, Biogen, Treasurer and Strategic Committee Member, ETHICS, Former Chief Compliance Officer EMEA, Wright Medical Inc., Former Senior Director, Compliance and Ethics, Business Program, EMEA, Bristol-Myers Squibb, Paris, France |
Gregoire Pavillon
Executive Director, European Association for the Study of the Liver (EASL), The Home of Hepatology
Geneva, Switzerland
|
Dr. Gudula Petersen
Chief Compliance Officer Europe & Australia, Grunenthal, Aachen, Germany |
Katalin Pungor
Director, HCCO Pharma Emerging Markets, Johnson & Johnson, Budapest, Hungary |
Nathalie Raynaud
Corporate Compliance Director, Global Compliance & Business Integrity Department, Sanofi, Paris, France
|
Brian Riewerts
Partner, Global Pharmaceuticals and Life Sciences, PwC LLP, Baltimore, MD, USA |
Christian-Claus Roth
Head Global Event Governance, Novartis, Pharma; Co-President, International Pharmaceutical Congress Advisory, Association (IPCAA), Berne, Switzerland |
Fabien Roy, DESS European Law
Senior Associate, Hogan Lovells, Brussels, Belgium
|
Christine Sainvil
Compliance Officer, EthicalMedTech, Brussels, Belgium |
Brian Sharkey, Esq.
Counsel, Porzio, Bromberg & Newman, Director of Compliance and Legal Affairs, Porzio Governmental Affairs, LLC, Morristown, NJ, USA |
Heather Simmonds
Director, Prescription Medicines Code of Practice Authority; Vice-Chair, IFPMA Code Compliance Network, London, UK
|
Nadine Sprangers
Senior Director Pricing, Reimbursement and Market Access, Daiichi Sankyo Europe GmbH, Munich, Germany |
Nina Stoeckel, LLM
Head of Group Compliance Programs, Merck KGaA, Darmstadt, Germany |
Michele Tagliaferri, Esq.
Counsel, Sidley Austin LLP, Brussels, Belgium
|
Melda Tanyeri, MS, MBA
Director, Fraud Investigation & Dispute Services, Ernst & Young, London, UK |
Marie Vandepaer
Senior Director Compliance Awareness and Solution-Corporate Compliance, UCB SA, Brussels Area, Belgium
|
Elisabethann Wright, Esq.
Partner, Hogan Lovells, Former Senior Legal Officer and Hearing Officer, EFTA Surveillance Authority, Brussels, Belgium |
Jose F. Zamarriego Izquierdo
Director Unidad de Supervision Deontologica, FARMAINDUSTRIA, Madrid, Spain
|
|
|
|
|
|
SPONSORED BY:
|
|
|
|
CO-SPONSORED BY:
|
|
|
|
CONGRESS CO CHAIRS
|
Ann Beasley
Chief Compliance Officer, Biogen, Former Global Compliance Officer, Novartis Pharma AG, Board Member and Co-chair, Strategic Committee International Society of Healthcare, Ethics, and Compliance Professionals (ETHICS), Cambridge, MA, USA
|
Dr. Michael Bartke
Director Compliance Management, DAIICHI SANKYO EUROPE GmbH, Co-chair, EFPIA Compliance Workgroup, Munich, Germany
|
Dominique Laymand, Esq.
Senior Vice President, Chief Ethics and Compliance Officer, Ipsen; President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France
|
Roeland Van Aelst
Regional Vice President - HCCO MD&D EMEA & Canada, Office Health Care Compliance and Privacy, Johnson & Johnson, Board Member, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Chairman, MedTech Compliance Network, Brussels, Belgium
|
|
|
|
CONTINUING EDUCATION CREDITS
|
Accounting Professionals: Approved for up to 13 NASBE CPE credits.
Compliance Professionals: Approved for up to 13.0 Compliance Certification Board CCB Credits.
Attorneys: The Congress is currently pending approval to offer California and Pennsylvania MCLE Credit.
Click here for more information.
|
|
GRANTORS:
|
|
DIAMOND
|
|
|
PLATINUM
|
|
|
GOLD
|
|
|
BRONZE
|
|
|
OTHER INTERNATIONAL PHARMA CONGRESSES
|
2007 - Brussels
2008 - Paris
2009 - Rome
2010 - Berlin
2011 - Istanbul
2011 - Singapore
2012 - Budapest
2012 - Shanghai
2012 - São Paulo
2013 - Madrid, Spain
2013 - Kuala Lumpur
2014 - Dubai
2014 - Mexico City
|
|
FOLLOW INTERNATIONAL PHARMA CONGRESS ON
|
Tweet using #PharmaCongress
|
|
PARTICIPATION OPTIONS
|
|
|
|
TRADITIONAL ONSITE ATTENDANCE
|
Simply register, travel to the conference city and attend in person.
Pros: subject matter immersion; professional networking opportunities; faculty interaction
|
|
LIVE AND ARCHIVED WEBCAST PARTICIPATION
|
Watch the conference in live streaming video over the Internet and at your convenience at any time 24/7 for the six months following the event.
The archived conference includes speaker videos and coordinated PowerPoint presentations.
Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office
|
WEBCAST INTERFACE SAMPLE
|
Click here for a sample stream
|
|
 This site complies with the HONcode standard for trustworthy health information:
verify here.
|
|
|
|
|
|
|
